1 active not recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Triprorelin Acetate: new trials by email Literature Review of Triprorelin Acetate trials Research Report on Triprorelin Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients GnRHa, Letrozole 2.5mg, Diane-35 - Endometrial Neoplasms, Atypical Endometrial Hyperplasia | Phase 2 / Phase 3 | Recruiting | Xiaojun Chen | 80 | 2022-07-13 | 2026-09-10 |
| Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG, Triprorelin Acetate - Endometrial Neoplasm Malignant Stage I | Phase 2 | Active not recruiting | Fudan University | 104 | 2022-03-11 | 2026-10-23 |
Endometrial Neoplasms (2) · Endometrial Hyperplasia (1) · Progesterone Resistance (1)
Fudan University (1) · Xiaojun Chen (1)
China (2)